Trial
NCT03110588
Phase I Trial of PACE for Metastatic Prostate Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
Astellas Pharma Inc; Sanofi
Condition
Metastatic Prostate Cancer
Intervention
PACE with Cabazitaxel (15 mg/m2)
Why stopped
PI left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-19